课题基金 / 基金详情

Genetic Epidemiology of Age-Related Macular Degeneration

Genetic Epidemiology of Age-Related Macular Degeneration
年龄相关性黄斑变性的遗传流行病学
批准号:
7683199
负责人:
DEBRA A SCHAUMBERG
金额:
$58.72万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2012-08-31

项目摘要

项目成果

DEBRA A SCHAUMBERG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD), the leading cause of incurable blindness among older adults in the US, is caused by interactions between underlying genetic susceptibility and lifestyle risk factors. However, our knowledge of the network of contributors to the pathogenesis of AMD remains incomplete, and treatment is inadequate. The proposed studies build upon a strong and growing foundation of research and invaluable existing resources to comprehensively study the genetic epidemiology of AMD. Through its use of archived DNA specimens from several large prospective cohort studies, this proposal represents a cost-effective, efficient, and informative approach to investigate the following specific aims: 1) determine the incidence rate ratio and attributable fraction for AMD in relation to common variants within a group of strong candidate genes including complement factor H, HTRA1/LOC387715, and others (candidates identified based on position, function, expression, etc.) using both single locus and haplotype analyses for AMD overall as well as for both dry and neovascular subtypes, 2) effectively utilize data derived from RNA microarray analysis of sibpairs extremely discordant for AMD to inform selection of candidate genes, 3) estimate the magnitude and significance of any gene-gene, or gene-environment interactions among these candidates and risk factors such as cigarette smoking, obesity, diet, and serum inflammatory markers. These aims will be accomplished through genotyping of >1300 confirmed incident AMD cases and >3000 controls in our high-tech core genotyping facility, along with direct sequencing when indicated for SNP discovery as well as to search for functional variants or disease-causing mutations if association analyses are significant. Unique strengths of this approach include the prospective design, large sample size, high-quality, high-throughput genotyping, integration with a study of extremely discordant sib-pairs, and state-of-the-art statistical analyses to provide precise estimates for effects of genes, gene-gene and gene-environment interactions. The proposed studies minimize bias through prospective assessment of exposures and AMD status, direct estimation of incidence rate ratios, novel candidate gene selection, and high statistical power. The long-term objective and clinical relevance of this research is to shed light on underlying biological mechanisms relevant to AMD, to suggest avenues for novel preventive or therapeutic approaches, and identify clinically useful risk assessments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Omega-3 Fatty Acids for Prevention of Dry Eye Disease: VITAL-DED
  • 批准号:
    8343444
  • 项目类别:
  • 资助金额:
    $40.16万
  • 财政年份:
    2012
  • 负责人:
    DEBRA A SCHAUMBERG
  • 依托单位:
Omega-3 Fatty Acids for Prevention of Dry Eye Disease: VITAL-DED
  • 批准号:
    8534136
  • 项目类别:
  • 资助金额:
    $36.13万
  • 财政年份:
    2012
  • 负责人:
    DEBRA A SCHAUMBERG
  • 依托单位:
Omega-3 Fatty Acids for Prevention of Dry Eye Disease: VITAL-DED
  • 批准号:
    8708876
  • 项目类别:
  • 资助金额:
    $37.32万
  • 财政年份:
    2012
  • 负责人:
    DEBRA A SCHAUMBERG
  • 依托单位:
Omega-3 Fatty Acids for Prevention of Dry Eye Disease: VITAL-DED
  • 批准号:
    8916119
  • 项目类别:
  • 资助金额:
    $5.87万
  • 财政年份:
    2012
  • 负责人:
    DEBRA A SCHAUMBERG
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: